Impact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis by Regensburger, Martin et al.
Stem Cell Reports
ReportImpact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis
Martin Regensburger,1,2,3 Iryna Prots,1,3 Dorothea Reimer,4 Sebastian Brachs,4,6 Sandra Loskarn,1,2,3
Dieter Chichung Lie,5 Dirk Mielenz,4,* and Beate Winner1,3,*
1Department of Stem Cell Biology, Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg (FAU), Glueckstrasse 6, Erlangen 91054, Germany
2Department of Neurology
3IZKF Junior Research Group III and BMBF Research Group Neuroscience
Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg (FAU), Erlangen 91054, Germany
4Department of Molecular Immunology, Department of Internal Medicine III, Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg (FAU), Glueckstrasse 6,
Erlangen 91054, Germany
5Emil-Fischer Centre, Institute of Biochemistry, Friedrich-Alexander-Universita¨t Erlangen-Nu¨rnberg (FAU), Erlangen 91054, Germany
6Present address: Charite´ - Universita¨tsmedizin Berlin, Department of Endocrinology&Metabolism and Center for Cardiovascular Research (CCR) as well as
Deutsches Zentrum fu¨r Herz-Kreislauf-Forschung (DZHK), partner site Berlin, 13347 Berlin, Germany
*Correspondence: dirk.mielenz@fau.de (D.M.), beate.winner@fau.de (B.W.)
https://doi.org/10.1016/j.stemcr.2017.12.010SUMMARYSwiprosin-1/Efhd2 (Efhd2) is highly expressed in the CNS during development and in the adult. EFHD2 is regulated by Ca2+ binding, sta-
bilizes F-actin, and promotes neurite extension. Previous studies indicated a dysregulation of EFHD2 in human Alzheimer’s disease
brains. We hypothesized a detrimental effect of genetic ablation of Efhd2 on hippocampal integrity and specifically investigated adult
hippocampal neurogenesis. Efhd2was expressed throughout adult neuronal development and in mature neurons. We observed a severe
reduction of the survival of adult newborn neurons in Efhd2 knockouts, starting at the early neuroblast stage. Spine formation and
dendrite growth of newbornneuronswere compromised in full Efhd2 knockouts, but not upon cell-autonomous Efhd2deletion. Together
with our finding of severe hippocampal tauopathy in Efhd2 knockout mice, these data connect Efhd2 to impaired synaptic plasticity as
present in Alzheimer’s disease and identify a role of Efhd2 in neuronal survival and synaptic integration in the adult hippocampus.INTRODUCTION
SWIPROSIN-1/EFHD2 (EFHD2) is an F-actin-stabilizing
protein, whose coiled-coil domain mediates dimerization
in a Ca2+-dependent manner. EFHD2 also acts as putative
cytoskeletal adaptor interacting with themicrotubule-asso-
ciated protein TAU (Ferrer-Acosta et al., 2013; Hagen et al.,
2012; Kwon et al., 2013). We have previously shown that
EFHD2 is highly expressed in the CNS throughout embry-
onic development and in the adult (Purohit et al., 2014).
The serine-threonine protein kinase cyclin-dependent
kinase 5 (CDK5) regulates the Ca2+-binding affinity of
EFHD2 by phosphorylation of EFHD2 at Ser74 (Va´zquez-
Rosa et al., 2014). CDK5 activity is dysregulated in Alz-
heimer’s disease (AD) and thereby promotes the formation
of amyloid beta and the hyperphosphorylation of TAU (Liu
et al., 2016). A potential involvement/dysregulation of
EFHD2 in AD was described previously in AD mouse
models and AD postmortem studies (Tseveleki et al.,
2010; Twine et al., 2011; Vega et al., 2008; Ferrer-Acosta
et al., 2013; Borger et al., 2014; Vega, 2016). These studies
suggested that EFHD2 interacts with TAU and TAU-associ-
ated proteins in AD.
Adult neurogenesis, the generation of new neurons in
the adult brain, persists throughout life within the dentate
gyrus (DG) of the hippocampus (Eriksson et al., 1998;
Spalding et al., 2013). Cdk5 is a modulator of adult neuro-
genesis (Jessberger et al., 2008), and knock down of overac-Stem Cell Re
This is an open access article under the Ctivated Cdk5 in mice transgenic for amyloid precursor pro-
tein rescued impaired neurogenesis (Crews et al., 2011).
Given (1) the link of both Efhd2 and Cdk5 to AD, (2) the
interaction between Cdk5 and Efhd2, and (3) the dysregula-
tion of adult neurogenesis in AD models and upon Cdk5
deletion, we hypothesized that deletion of Efhd2 nega-
tively affects adult neurogenesis. Efhd2 is broadly expressed
in the adult neurogenic niche. We demonstrate a severe
decrease of adult neurogenesis in the DG of Efhd2/.
There is defective integration of newborn neurons in
Efhd2/. We propose a cell-extrinsic mechanism of Efhd2
deficiency mediated by increased levels of phosphorylated
TAU in the hippocampus of Efhd2/ mice. Our findings
describe a role of Efhd2 in the adult hippocampal stem
cell niche and have potential implications for tauopathies
such as AD.RESULTS
Efhd2 Is Expressed during Adult Neuronal
Development
To investigate the role of Efhd2 in the adult hippocampus,
we first studied hippocampal expression in adult Efhd2/
knockout/LacZ knockin mice. In this model, both Efhd2
alleles were replaced by a LacZ reporter gene downstream
of the Efhd2 promoter (Brachs et al., 2014). In the hippo-
campus, we found high Efhd2 gene expression in the cornuports j Vol. 10 j 347–355 j February 13, 2018 j ª 2017 The Authors. 347
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Figure 1. Efhd2 Is Expressed in the
Mouse Hippocampus and Efhd2 Knockout
Impairs Survival of Newborn Neurons
(A) Beta-Gal staining of the DG of Efhd2+/+
(outline indicated by white dots), Efhd2+/,
and Efhd2/ mice showing expression of
the Efhd2 locus in the adult DG (immuno-
histochemistry for LacZ is shown in detail in
Figure S1).
(B–F) Analysis of proliferation at the age
of 4 months. (B) Immunohistochemistry
for PCNA. (C) There was no significant
difference of PCNA numbers in Efhd2/
compared with Efhd2+/+. (D) In a separate
experiment, animals received a single in-
jection of EdU. (E) EdU-positive cells in
the dentate gyrus were quantified after
4 hr. (F) Quantification of EdU-positive cells
showed no change in Efhd2/.
(G–K) Survival and neuronal differentiation
were analyzed 31 days after BrdU labeling.
(H) Low- and (I) high-magnification images
of BrdU/NeuN colabeling. (J) In Efhd2/,
the number of BrdU-positive cells was
significantly reduced after 31 days. (K) The
number of BrdU/NeuN double-positive
cells (newborn neurons) was significantly
reduced in Efhd2/. dpi, days after injec-
tion; hrs pi, hours after injection. *p < 0.05;
**p < 0.01.
Data are represented as mean ± SEM, n = 5
animals per genotype for all quantifica-
tions. For all analyses, animals were
4 months of age. Scale bars, (A) and (H)
100 mm, (B), (E), and (I) 25 mm.ammonis regions CA1 and CA2 and in the DG (Figures 1A,
S1A, and S1B).
In the DG, Efhd2 was not only expressed in NeuN-
positive mature neurons, but also in Sox2-positive
radial glia-like cells and DCX-positive neuroblasts (Fig-
ures S1C–S1G). The observed expression in adult neural348 Stem Cell Reports j Vol. 10 j 347–355 j February 13, 2018stem cells correlates with expression of Efhd2 in murine
embryonic stem cells (data not shown). As shown previ-
ously (Fischer et al., 2005; Jessberger et al., 2008), p35,
the regulatory subunit of CDK5, was expressed in the
DG, including its expression in DCX-positive neuroblasts
(Figure S1H).
Observing widespread expression of Efhd2 in the DG,
we analyzed total DG volumes. DG volume was compara-
ble between Efhd2/ and Efhd2+/+, suggesting that the
overall structure of the DG was unchanged in Efhd2/
mice (Figures S2A and S2B; Table S1). The total number
of NeuN-positive neurons in the granule cell layer was un-
changed (Figure S2C) and zinc-transporter-3-based anal-
ysis of the mossy fiber pathway area showed comparable
sizes of the axonal compartment of DG neurons in
Efhd2/ and controls (Figures S2D–S2G). These results
suggest that the overall anatomy of the DG is unchanged
in Efhd2/.
Compromised Survival of Adult Newborn Neurons in
Efhd2/
Observing expression of Efhd2 throughout adult neuronal
development, we hypothesized a role of Efhd2 for adult
neurogenesis. We first analyzed proliferation within the
DG using the marker PCNA, which was not altered in
4-month-old Efhd2/ mice (Figures 1B and 1C). This
result was confirmed by 5-ethynyl-20-deoxyuridine (EdU)
labeling of proliferating cells, which was unchanged
4 hr after labeling in Efhd2/ (Figures 1D–1F). Next,
bromodeoxyuridine (BrdU) was applied to 3-month-old
Efhd2/ mice and controls. We observed a severely
decreased number of BrdU-positive cells in Efhd2/
1 month after BrdU-injection (427 ± 92 cells per hemi-
sphere ± SD in EFhd2/ versus 716 ± 241 in controls;
p < 0.05; Figures 1G–1J). The fraction of NeuN-positive
cells among BrdU-positive cells in Efhd2/ was similar
to controls. This indicates that the rate of neuronal differ-
entiation is not altered (Table S1). When calculating
the number of newborn neurons, we found a 46% reduc-
tion of the total number of BrdU/NeuN double-positive
newborn neurons after 1 month (318 ± 28 in Efhd2/
versus 592 ± 201 in controls; p < 0.01; Figure 1K). Given
this profound reduction of surviving newborn neurons
despite unchanged DG volume and neuron numbers,
our findings suggest that neurogenesis is compromised
in Efhd2/ specifically in the adult.
Loss of Neuroblasts and Increased Cell Death in
Efhd2/ Mice
We next aimed to determine the stage at which adult-born
neurons are lost in the Efhd2/DG.We analyzed the num-
ber of BrdU-positive cells 14 days after labeling and
observed a significant decrease by 60% in Efhd2/ (Figures
2A and 2B). Immature adult-generated hippocampal neu-
rons undergo well-defined morphological changes during
their maturation (Brown et al., 2003; Couillard-Despres
et al., 2005) which allows the identification of devel-
opmental subpopulations (Figure 2E). Comparing the
numbers of early, intermediate, and late-stage DCX-posi-tive cells, we found a significant reduction in Efhd2/ per-
sisting from the early through to the late stage (Figures 2C
and 2D). To determine whether there is an additional selec-
tive loss of intermediate or late-stage neuroblasts, we calcu-
lated the relative loss of DCX-positive cells and found no
significant differences (Table S1).
As we observed a marked decrease of newly born neu-
rons despite unchanged proliferation, we next analyzed
whether cell death was altered in the Efhd2/ hippocam-
pus. Indeed, the number of cells positive for activated cas-
pase-3 was significantly increased in the DG of Efhd2/
mice (Figures 2F–2H).
Efhd2-Deletion Affects Dendrite Outgrowth and Spine
Formation of Adult Newborn Neurons
To determine whether Efhd2 knockout also impacts the
morphogenesis of surviving newborn neurons, we stereo-
tactically delivered a GFP retrovirus into the DG at the
age of 3 months to label newborn neurons, and analyzed
their morphology after 1 month of survival (Figures
3A and 3B; Zhao et al., 2006). Total dendrite length
of GFP-labeled neurons was decreased by 38% (328 ±
149 mm [mean ± SD] in Efhd2/ animals versus 526 ±
170 in controls; p < 0.05). This finding was substantiated
by Sholl analysis which showed a significant reduction
of dendrite complexity at intermediate distances from
the soma, i.e., at 100–150 mm (Figure 3E). The number
of branching points was unchanged between groups (Fig-
ure 3C) indicating intact branching of newborn neurons’
dendrites.
The density of dendritic spines was significantly reduced
by 59% in Efhd2/ (0.501 ± 0.220 spines per mm ± SD in
Efhd2/ DG versus 1.21 ± 0.271 in controls; p < 0.05; Fig-
ure 3F). The subpopulation of mushroom spines was iden-
tified based on morphological criteria of spine head size
(Zhao et al., 2006).We found that the density ofmushroom
spines was also significantly decreased by 54% in the
absence of Efhd2 (14.5 ± 8.5 mushroom spines per nm ±
SD in Efhd2/ DG versus 31.3 ± 1.6 in controls; p < 0.01;
Figure 3G). This reduction of spines, and in particular
of mushroom spines, provides further evidence for an
impairment of dendritic integration of newborn neurons
into the molecular layer of Efhd2/ mice.
To separate cell-autonomous from cell-non-autonomous
effects in Efhd2/ mice, we made use of a newly generated
Efhd2fl/fl mousemodel, where exon 2 of the Efhd2 gene had
been flanked by loxP sites and is deleted uponCre-mediated
recombination (Figure S3). Conditional deletion of Efhd2
in adult newborn cells in the DG was induced by a retro-
virus expressing both GFP and Cre (GFP-Cre). As only few
cells are infected using this approach, while the majority
of surrounding neurons maintains normal Efhd2 expres-
sion, it allows the specific investigation of cell-autonomousStem Cell Reports j Vol. 10 j 347–355 j February 13, 2018 349
Figure 2. Loss of Neuroblasts and
Increased Cell Death in the Adult
Efhd2/ Dentate Gyrus
(A) To analyze early survival of newly
generated cells, animals were killed on day
14 after BrdU labeling.
(B) There was a significantly reduced sur-
vival of BrdU-positive cells at 14 days in
Efhd2/.
(C) The total number of DCX-positive cells
was significantly reduced in Efhd2/ mice.
(D and E) Different developmental stages
during neuroblast maturation were distin-
guished based upon morphological criteria.
Early-stage neuroblasts are located in the
subgranular zone, form clusters, and exhibit
no processes or processes with parallel
orientation. Intermediate neuroblasts are
located in the granule cell layer and
exhibit one or more processes confined to
the granule cell layer. Late neuroblasts are
located in the granule cell layer and display
processes extending into the molecular
layer. (D) There was a significant reduction
of early, intermediate, and late neuroblasts
in Efhd2/ mice. (E) Overview images of
doublecortin-positive neuroblasts in con-
trols and Efhd2/ mice at different stages,
as described above.
(F and G) Low-magnification images of
activated caspase-3 immunostaining in the
dentate gyrus of Efhd2+/+ and Efhd2/ (F)
and magnifications from boxed areas (G).
(H) The number of activated caspase-3-
positive cells was significantly increased in
the dentate gyrus of Efhd2/ mice.
Data are represented as mean ± SEM, n = 5
animals per genotype, aged 4 months for
all analyses. Scale bars, 100 mm (F), 25 mm
(E and G). *p < 0.05, **p < 0.01.Efhd2 deletion in newborn neurons. Comparing the
morphologies of adult newborn neurons infected with
GFP-Cre versus GFP only, we observed no differences in
dendritic branching points, dendrite length, spine density,350 Stem Cell Reports j Vol. 10 j 347–355 j February 13, 2018andmushroom spine density (Figures 3H–3N). This finding
strongly indicates a cell-non-autonomous mechanism
of impaired dendritic morphology of newborn neurons in
the adult hippocampus of Efhd2/ mice.
Figure 3. Compromised Dendrite Length and Spine Density of Mature Newborn Neurons in Efhd2/, but Not Upon Conditional
Efhd2 Deletion
(A) CAG-GFP retrovirus was stereotactically injected into the hippocampus of 3-month-old wild-type and Efhd2/ mice, perfusion was
performed 31 days later.
(B) Representative images of retrovirally labeled GFP-expressing newborn neurons in wild-type and Efhd2/ mice, as well as spine
micrographs and mushroom spine magnifications (boxed).
(C and D) The number of dendritic branching points is unchanged in Efhd2/ mice (C), but the total length of the dendritic tree is
significantly reduced (D).
(E) Sholl analysis shows that there are significantly less dendritic branches in a distance of 100 and 150 mm from the soma.
(F) The density of dendritic spines is significantly reduced in Efhd2/ mice.
(G) The density of mushroom spines is significantly reduced in Efhd2/ mice.
(H) Conditional knock out of Efhd2 in newborn neurons by application of a retrovirus encoding GFP and Cre recombinase (GFP-Cre) in
3-month-old mice, where the Efhd2 locus had been floxed (Efhd2fl/fl; see also Figure S3).
(I) Representative images of GFP- and GFP-Cre-expressing newborn neurons in Efhd2fl/fl mice, as well as spine micrographs and mushroom
spine magnifications (boxed).
(J and K) There is no difference in the number of branching points and the length of the dendritic tree.
(L) Sholl analysis of GFP versus GFP-Cre overexpressing neurons.
(legend continued on next page)
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Increased Levels of Phosphorylated TAU in the
Hippocampus of Efhd2/
Multiple lines of evidence suggest a role of Efhd2 in
AD pathogenesis (Mielenz and Gunn-Moore, 2016; Vega,
2016). We thus analyzed expression of pSer202/pThr205
TAU. Using immunohistochemistry, we found that phos-
pho-TAU levels were significantly increased in the hippo-
campus of Efhd2/ compared with controls, including
all hippocampal areas analyzed (molecular layer, DG, and
hilus; Figures 4A–4D). Moreover, western blot of whole-
brain lysates showed abundant presence of phospho-TAU
in Efhd2/, compared with very low expression levels
in controls (Figures 4E and 4F). We conclude that lack of
Efhd2 leads to increased levels of phospho-TAU and may
be directly connectedwith decreased survival and dendritic
integration of adult newborn neurons.DISCUSSION
In summary, we show that Efhd2 is strongly expressed in
the adult hippocampal neurogenic niche. In Efhd2/
mice, the numbers of neuroblasts and of newborn neurons
are markedly reduced. Surviving neurons exhibit impaired
dendrite morphology and a reduced number of spines and
mushroom spines. This defective dendritic integration is
due to a cell-extrinsic mechanism of Efhd2 deficiency and
is accompanied by increased levels of phosphorylated
TAU in the hippocampus of Efhd2/ mice. Our findings
thus broaden the knowledge about the emerging role of
Efhd2 in TAU-related neurodegeneration and describe a
function of Efhd2 in adult neurogenesis.
A multiplicity of regulatory factors impacting the
different stages of adult neurogenesis have been identified,
highlighting the exact balance that is needed for the proper
functionof adult newbornneurons (Gonc¸alves et al., 2016).
Our results demonstrate a role of Efhd2 in the adult hippo-
campus, specifically for survival and postsynaptic integra-
tion of newborn neurons. Mushroom spines are sites of sta-
ble synaptic input and are thusmajormediators ofmemory
engram.Adult newbornneurons are critical formemory en-
coding involving pattern-separation tasks (Aimone et al.,
2014). Particularly in light of the animals’ increased levels
of phospho-TAU, characterization of memory function in
Efhd2/ mice will be an important future experiment.
Volumetry of the DG and of the mossy fiber pathway, as
well as the total number of neurons in the granule cell(M and N) There were no significant differences in spine density and
neurons.
Data are represented as mean ± SEM, n = 5 per group (paradigm A), n =
(upper line) and 10 mm (lower line) in (B and I).
352 Stem Cell Reports j Vol. 10 j 347–355 j February 13, 2018layer, showed no alterations in Efhd2/ mice. In line
with this intact overall morphology, the embryonic devel-
opment of the CNS in terms of brain volumes and synaptic
marker expression were unchanged at the macroscopic
level in Efhd2/ mice (Purohit et al., 2014).
We observe that Efhd2/ neurons display normal
dendrite/spine morphology when allowed to develop in a
wild-type hippocampal neurogenic niche. These observa-
tions imply that cell-extrinsic factors play a major role in
the integration deficit observed in Efhd2/ mice.
We describe major survival deficits of newborn neu-
rons at an early stage. We presently cannot distinguish
whether the loss of newborn neurons is caused by cell-
intrinsic or -extrinsic mechanisms or by both. In adult-
born neurons, intracellular Ca2+ levels are influenced by
excitatory stimuli and are critical for survival (Deisseroth
et al., 2004). The Ca2+-binding protein EFHD2 operates
downstream of CDK5. Intriguingly, CDK5 was reported
to cell autonomously regulate survival of adult-born neu-
rons (Lagace et al., 2008). These observations raise the
interesting possibility that a CDK5 EFHD2 pathway may
be involved in regulating the survival of adult-born
neurons.
Strikingly, we observe an increased phospho-TAU
expression in the Efhd2/ hippocampus. Multiple lines
of evidence have shown alterations of adult neurogenesis
in neurodegenerative diseases including AD (Winner
et al., 2011). Loss of dendritic spines is a hallmark of
AD and is also found in adult newborn neurons in trans-
genic AD models (Sun et al., 2009). A deficit of the total
rate of neurogenesis precedes neuropathology in both
the triple-transgenic (APP/PSEN1/TAU) and in the
genomic TAU mouse model (Demars et al., 2010; Komuro
et al., 2015). This indicates that adult neurogenesis may
already be affected during early-stage AD pathological
events.
Our results of defective integration of newborn neurons
in the Efhd2/DGand increased phospho-TAU expression
thus raise the intriguing possibility that this adult hippo-
campal Efhd2-related phenotype reflects an early neuritic
phenotype of neurodegeneration, and that EFHD2, with
its actin-binding ability, has a neuroprotective function.
It will be interesting to investigate TAU-associated neurode-
generation in aging Efhd2/ mice in more detail in the
future. Increased levels of phospho-TAU in the hippocam-
pus of Efhd2/ animals suggest a neuroprotective role of
Efhd2.mushroom spine density between GFP- and GFP-Cre-overexpressing
4 per group (paradigm H). *p < 0.05, **p < 0.01. Scale bars, 50 mm
Figure 4. Increased Phospho-TAU Levels
in Efhd2/
(A–D) Representative images of immuno-
histochemistry for pSer202/pThr205-TAU
(AT8 antibody, green) in controls and
Efhd2/ mice, respectively (A). Analysis of
the integrated density of phospho-TAU
staining shows significantly increased levels
in the molecular layer (B), the dentate gyrus
(C), and the hilus (D) of Efhd2/ mice.
(E) Western blot for pSer202/pThr205-TAU
shows prominent expression of TAU and
predominantly phospho-TAU in Efhd2/,
but not in controls. Hsc70 served as loading
control.
(F) Quantification of the optical density of
phospho-TAU in Efhd2/, normalized to
Hsc70.
Data are represented as mean ± SEM. (B–D)
n = 4 per genotype (age 4 months); (F) n = 3
per genotype (age 3 months).
Scale bars, 100 mm. *p < 0.05, **p < 0.01.EXPERIMENTAL PROCEDURES
Animals
Animal experiments were conducted in accordance with the Euro-
pean Communities Council Directive of November 24th, 1996,
and were approved by the local governmental administration for
animal health (permit numbers: 54-2532.1-21/09 and 54.2532.1–
18/14). In Efhd2/ mice, the entire Efhd2 gene was replaced by a
b-Gal reporter gene as described elsewhere (Brachs et al., 2014).
Retrovirus-Mediated Labeling and Analysis of
Newborn Neurons
A Moloney murine leukemia retrovirus-based CAG-GFP plasmid
was used as described earlier (Zhao et al., 2006). CAG-GFP drives
expression of EGFP by the compound promoter CAG. A CAG-
GFP-IRES-CRE plasmid had been generated from the original
CAG-GFP vector by insertion of an IRES-Cre coding sequence
(Jagasia et al., 2009). A concentrated viral solution was titered to
4 3 108 pfu/mL. A stereotaxic frame (Kopf Instruments) was used
for sequential bilateral infusion into the DG (AP –2.00 mm, ML ±
1.6 mm from bregma, DV –2.3 mm from skull; n = 5 per genotype
for Efhd2+/+ versus Efhd2/; n = 4 per construct for GFP versus
GFP-Cre). A total volumeof 1.0 mLwas slowly infused (0.2 mL/min).Statistical Analysis
For statistical analysis with Prism (GraphPad Software), signifi-
cance level was assumed at 0.05. All parameters (cell counts, vol-
umes, dendrite length, number of branching points, spine density,
and mushroom spine density) were compared using unpaired,
two-sided Student’s t tests.
Details on the generation of Efhd2fl/fl mice, BrdU/EdU treatment,
tissue processing, immunohistochemistry, microscopy, and west-
ern blot can be found in the Supplemental Information.
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